Shuqian Liu1, James M Hempe1, Robert J McCarter1, Shengxu Li1, Vivian A Fonseca1. 1. Department of Medicine (S.L., V.A.F.), Tulane University Health Sciences Center, New Orleans, Louisiana 70112; Department of Global Health System and Development (S.L.), School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana 70112; Department of Pediatrics (J.M.H.), Louisiana State University Health Sciences Center and Children's Hospital Research Institute for Children, New Orleans, Louisiana 70118; Research Division of Biostatistics and Study Methodology (R.J.M.), Children's National Medical Center, Washington, District of Columbia 20010; Department of Epidemiology (S.L.), School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana 70112.
Abstract
CONTEXT: Inflammation is associated with higher glycated hemoglobin (HbA1c) levels. Whether the relationship is independent of blood glucose concentration remains unclear. OBJECTIVE: The hemoglobin glycation index (HGI) was used to test the hypothesis that interindividual variation in HbA1c is associated with inflammation. PARTICIPANTS: This study used nondiabetic adults from the National Health and Nutrition Examination Survey (1999-2008). MAIN OUTCOME MEASURES: A subsample of participants was used to estimate the linear regression relationship between HbA1c and fasting plasma glucose (FPG). Predicted HbA1c were calculated for 7323 nondiabetic participants by inserting FPG into the equation, HbA1c = 0.017 × FPG (mg/dL) + 3.7. HGI was calculated as the difference between the observed and predicted HbA1c and the population was divided into low, moderate, and high HGI subgroups. Polymorphonuclear leukocytes (PMNL), monocytes, and C-reactive protein (CRP) were used as biomarkers of inflammation. RESULTS: Mean HbA1c, CRP, monocyte, and PMNL levels, but not FPG, progressively increased in the low, moderate, and high HGI subgroups. There were disproportionately more Blacks than whites in the high HGI subgroup. CRP (ß, 0.009; 95% confidence interval [CI], 0.0001-0.017), PMNL (ß, 0.036; 95% CI, 0.010-0.062), and monocyte count (ß, 0.072; 95% CI, 0.041-0.104) were each independent predictors of HGI after adjustment for age, sex, race, triglycerides, hemoglobin level, mean corpuscular volume, red cell distribution width, and obesity status. CONCLUSIONS: HGI reflects the effects of inflammation on HbA1c in a nondiabetic population of U.S. adults and may be a marker of risk associated with inflammation independent of FPG, race, and obesity.
CONTEXT: Inflammation is associated with higher glycated hemoglobin (HbA1c) levels. Whether the relationship is independent of blood glucose concentration remains unclear. OBJECTIVE: The hemoglobin glycation index (HGI) was used to test the hypothesis that interindividual variation in HbA1c is associated with inflammation. PARTICIPANTS: This study used nondiabetic adults from the National Health and Nutrition Examination Survey (1999-2008). MAIN OUTCOME MEASURES: A subsample of participants was used to estimate the linear regression relationship between HbA1c and fasting plasma glucose (FPG). Predicted HbA1c were calculated for 7323 nondiabetic participants by inserting FPG into the equation, HbA1c = 0.017 × FPG (mg/dL) + 3.7. HGI was calculated as the difference between the observed and predicted HbA1c and the population was divided into low, moderate, and high HGI subgroups. Polymorphonuclear leukocytes (PMNL), monocytes, and C-reactive protein (CRP) were used as biomarkers of inflammation. RESULTS: Mean HbA1c, CRP, monocyte, and PMNL levels, but not FPG, progressively increased in the low, moderate, and high HGI subgroups. There were disproportionately more Blacks than whites in the high HGI subgroup. CRP (ß, 0.009; 95% confidence interval [CI], 0.0001-0.017), PMNL (ß, 0.036; 95% CI, 0.010-0.062), and monocyte count (ß, 0.072; 95% CI, 0.041-0.104) were each independent predictors of HGI after adjustment for age, sex, race, triglycerides, hemoglobin level, mean corpuscular volume, red cell distribution width, and obesity status. CONCLUSIONS: HGI reflects the effects of inflammation on HbA1c in a nondiabetic population of U.S. adults and may be a marker of risk associated with inflammation independent of FPG, race, and obesity.
Authors: Tiejian Wu; Joan P Dorn; Richard P Donahue; Christopher T Sempos; Maurizio Trevisan Journal: Am J Epidemiol Date: 2002-01-01 Impact factor: 4.897
Authors: Arlette A Soros; Stuart A Chalew; Robert J McCarter; Rachel Shepard; James M Hempe Journal: Pediatr Diabetes Date: 2010-11 Impact factor: 4.866
Authors: Daniel S Hsia; Neda Rasouli; Anastassios G Pittas; Christine W Lary; Anne Peters; Michael R Lewis; Sangeeta R Kashyap; Karen C Johnson; Erin S LeBlanc; Lawrence S Phillips; James M Hempe; Cyrus V Desouza Journal: J Clin Endocrinol Metab Date: 2020-03-01 Impact factor: 5.958
Authors: Sara J Coulon; Cruz Velasco-Gonzalez; Richard Scribner; Chi L Park; Ricardo Gomez; Alfonso Vargas; Sarah Stender; Jovanny Zabaleta; Patrice Clesi; Stuart A Chalew; James M Hempe Journal: Pediatr Diabetes Date: 2016-01-18 Impact factor: 4.866
Authors: Likang Li; Gregory Y H Lip; Shuai Li; Jonathan D Adachi; Lehana Thabane; Guowei Li Journal: Cardiovasc Diabetol Date: 2022-07-15 Impact factor: 8.949
Authors: Dorte Vistisen; Daniel R Witte; Eric J Brunner; Mika Kivimäki; Adam Tabák; Marit E Jørgensen; Kristine Færch Journal: Diabetes Care Date: 2018-02-16 Impact factor: 19.112
Authors: Maria Ly; Cyrus A Raji; Gary Z Yu; Qing Wang; Yong Wang; Suzanne E Schindler; Hongyu An; Amjad Samara; Sarah A Eisenstein; Tamara Hershey; Gordon Smith; Samuel Klein; Jingxia Liu; Chengjie Xiong; Beau M Ances; John C Morris; Tammie L S Benzinger Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472